These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 20651587)
1. More on Hans Biberstein and his original ideas of vaccination against human warts and herpes infection. Grzybowski A; Jabłońska S Am J Dermatopathol; 2010 Dec; 32(8):851-2. PubMed ID: 20651587 [TBL] [Abstract][Full Text] [Related]
2. Josef jadassohn--an appreciation on the occasion of his 150th birthday. Weyers W Am J Dermatopathol; 2013 Oct; 35(7):742-51. PubMed ID: 23928455 [TBL] [Abstract][Full Text] [Related]
3. The man behind the eponym: Hans Biberstein and follicular hyperplasia overlying dermatofibroma. Hamel J; Burgdorf WH; Bräuninger W Am J Dermatopathol; 2009 Oct; 31(7):710-4. PubMed ID: 19633531 [TBL] [Abstract][Full Text] [Related]
4. [Letter: Immunization against varicella (the priority of Pál Ferencz)]. Boda D Orv Hetil; 1975 Nov; 116(47):2807. PubMed ID: 172830 [No Abstract] [Full Text] [Related]
5. [Jenner and Pirjo]. Eskola J; Huttunen J Duodecim; 1996; 112(9):787-8. PubMed ID: 10592964 [No Abstract] [Full Text] [Related]
6. Human papillomavirus vaccines: a warty problem. Galloway DA Infect Agents Dis; 1994 Aug; 3(4):187-93. PubMed ID: 7827787 [TBL] [Abstract][Full Text] [Related]
7. HPV and HPV-associated diseases. Dunne EF; Park IU Infect Dis Clin North Am; 2013 Dec; 27(4):765-78. PubMed ID: 24275269 [TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of an adjuvanted human papillomavirus (HPV) type 6 L2E7 vaccine: infection of external anogenital warts with multiple HPV types and failure of therapeutic vaccination. Vandepapeliere P; Barrasso R; Meijer CJ; Walboomers JM; Wettendorff M; Stanberry LR; Lacey CJ J Infect Dis; 2005 Dec; 192(12):2099-107. PubMed ID: 16288373 [TBL] [Abstract][Full Text] [Related]
12. Two 17th century skin balms for warts and pimples? Hardy A; Rollinson G Pharm Hist (Lond); 2016 Sep; 46(3):50-5. PubMed ID: 29999265 [No Abstract] [Full Text] [Related]
13. The use of yellow fever virus modified by in vitro cultivation for human immunization. J. Exp. Med. 65, 787-800 (1937). Theiler M; Smith HH Rev Med Virol; 2000; 10(1):6-16; discussion 3-5. PubMed ID: 10654001 [No Abstract] [Full Text] [Related]
14. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ; MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109 [TBL] [Abstract][Full Text] [Related]
15. Analysis of risk-structured vaccination model for the dynamics of oncogenic and warts-causing HPV types. Alsaleh AA; Gumel AB Bull Math Biol; 2014 Jul; 76(7):1670-726. PubMed ID: 25033777 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented? Shaw AR Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009 [TBL] [Abstract][Full Text] [Related]
20. Rinderpest: the end of cattle plague. Roeder PL Prev Vet Med; 2011 Nov; 102(2):98-106. PubMed ID: 21783268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]